Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.3561
+0.0027 (0.76%)
At close: Jun 18, 2025, 4:00 PM
0.3559
-0.0002 (-0.06%)
After-hours: Jun 18, 2025, 7:58 PM EDT
MRSN's stock price has decreased by -82.54% in the past year and price targets may not have had time to catch up.
Mersana Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$5.75
Upside
+1,514.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +2,708.20% | May 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,304.10% | May 16, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 6, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +1,304.10% | Aug 27, 2024 |
| Baird | Baird | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +742.46% | Aug 14, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $5 | Sell → Hold | Upgrades | $5 | +1,304.10% | Mar 19, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades $2 → $7 | Hold → Buy | Upgrades | $2 → $7 | +1,865.74% | Feb 29, 2024 |
| Truist Securities | Truist Securities | Hold → Strong Buy Upgrades $9 | Hold → Strong Buy | Upgrades | $9 | +2,427.38% | Feb 29, 2024 |
| Baird | Baird | Hold Maintains $1 → $5 | Hold | Maintains | $1 → $5 | +1,304.10% | Feb 29, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $7 | Hold → Strong Buy | Upgrades | $7 | +1,865.74% | Feb 29, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $1 → $5 | Hold → Strong Buy | Upgrades | $1 → $5 | +1,304.10% | Dec 4, 2023 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $10 → $1 | Strong Buy → Hold | Downgrades | $10 → $1 | +180.82% | Jul 28, 2023 |
| Baird | Baird | Buy → Hold Downgrades $7 → $1 | Buy → Hold | Downgrades | $7 → $1 | +180.82% | Jul 28, 2023 |
| Wedbush | Wedbush | Buy → Hold Downgrades $12 → $2 | Buy → Hold | Downgrades | $12 → $2 | +461.64% | Jul 27, 2023 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 27, 2023 |
| Citigroup | Citigroup | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +2,708.20% | Jun 16, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.